These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26847993)

  • 1. Next-Generation Molecular Testing of Newborn Dried Blood Spots for Cystic Fibrosis.
    Lefterova MI; Shen P; Odegaard JI; Fung E; Chiang T; Peng G; Davis RW; Wang W; Kharrazi M; Schrijver I; Scharfe C
    J Mol Diagn; 2016 Mar; 18(2):267-82. PubMed ID: 26847993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.
    Baker MW; Atkins AE; Cordovado SK; Hendrix M; Earley MC; Farrell PM
    Genet Med; 2016 Mar; 18(3):231-8. PubMed ID: 25674778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis.
    Sontag MK; Lee R; Wright D; Freedenberg D; Sagel SD
    J Pediatr; 2016 Aug; 175():150-158.e1. PubMed ID: 27131402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-step NGS molecular analysis of the CFTR gene on newborn dried blood spots gives a higher diagnostic sensitivity in affected and carrier subjects: A pilot study.
    Nunziato M; Starnone F; Giordano S; D'Antonio M; Scognamiglio D; Esposito MV; Correra A; Di Maggio F; D'Argenio V; Scaglione GL; Castaldo G; Salvatore F
    Clin Chim Acta; 2024 Jan; 552():117625. PubMed ID: 37923102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing Technology.
    Lucarelli M; Porcaro L; Biffignandi A; Costantino L; Giannone V; Alberti L; Bruno SM; Corbetta C; Torresani E; Colombo C; Seia M
    J Mol Diagn; 2017 Sep; 19(5):788-800. PubMed ID: 28736296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of 31 CFTR mutations by polymerase chain reaction/oligonucleotide ligation assay in a pilot screening of 4476 newborns for cystic fibrosis.
    Gasparini P; Arbustini E; Restagno G; Zelante L; Stanziale P; Gatta L; Sbaiz L; Sedita AM; Banchieri N; Sapone L; Fiorucci GC; Brinson E; Shulse E; Rappaport E; Fortina P
    J Med Screen; 1999; 6(2):67-9. PubMed ID: 10444722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots For Newborn Screening Without Carrier Identification.
    DiBattista A; McIntosh N; Lamoureux M; Al-Dirbashi OY; Chakraborty P; Britz-McKibbin P
    J Proteome Res; 2019 Mar; 18(3):841-854. PubMed ID: 30507207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis: A Simple and Customized Strategy for Genetic Screening Able to Detect Over 90% of Identified Mutated Alleles in Brazilian Newborns.
    Rispoli T; Rodrigues GM; de Castro SM; Prado MJ; da Silva CMD; Grandi T; Fischer GB; Pinto LA; Maróstica PJC; Scortegagna LCR; Mocelin HT; Vargas JE; Rossetti MLR
    Mol Diagn Ther; 2020 Jun; 24(3):315-325. PubMed ID: 32185651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System.
    Rispoli T; Martins de Castro S; Grandi T; Prado M; Filippon L; Dornelles da Silva CM; Vargas JE; Rossetti LMR
    J Pediatr; 2018 Aug; 199():272-277.e3. PubMed ID: 29731357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
    Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
    Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genetic analysis of the cystic fibrosis transmembrane conductance regulator from dried blood specimens--implications for newborn screening.
    Kammesheidt A; Kharrazi M; Graham S; Young S; Pearl M; Dunlop C; Keiles S
    Genet Med; 2006 Sep; 8(9):557-62. PubMed ID: 16980811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn Screening for Cystic Fibrosis in California.
    Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L;
    Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation diagnostics of cystic fibrosis and CFTR-related disorders by targeted multiplex high-coverage resequencing of CFTR.
    Trujillano D; Ramos MD; González J; Tornador C; Sotillo F; Escaramis G; Ossowski S; Armengol L; Casals T; Estivill X
    J Med Genet; 2013 Jul; 50(7):455-62. PubMed ID: 23687349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations.
    Sommerburg O; Krulisova V; Hammermann J; Lindner M; Stahl M; Muckenthaler M; Kohlmueller D; Happich M; Kulozik AE; Votava F; Balascakova M; Skalicka V; Stopsack M; Gahr M; Macek M; Mall MA; Hoffmann GF
    J Cyst Fibros; 2014 Jan; 13(1):15-23. PubMed ID: 23891278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Diagnostics of Cystic Fibrosis in Serbia: Our Approach to Meet the Diagnostic Challenges.
    Divac Rankov A; Kusic-Tisma J; Ljujic M; Nikolic A; Milosevic K; Vilotijevic Dautovic G; Radojkovic D
    Genet Test Mol Biomarkers; 2020 Apr; 24(4):212-216. PubMed ID: 32286879
    [No Abstract]   [Full Text] [Related]  

  • 18. Newborn cystic fibrosis screening in southeastern Mexico: Birth prevalence and novel CFTR gene variants.
    Ibarra-González I; Campos-Garcia FJ; Herrera-Pérez LDA; Martínez-Cruz P; Moreno-Graciano CM; Contreras-Capetillo SN; León-Burgos V; Maldonado-Solis FA; Alcántara-Ortigoza MA; González Del Angel A; Vela-Amieva M
    J Med Screen; 2018 Sep; 25(3):119-125. PubMed ID: 28992757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diagnostic Next-Generation sequencing: the case of CFTR carrier screening.
    Loukas YL; Thodi G; Molou E; Georgiou V; Dotsikas Y; Schulpis KH
    Scand J Clin Lab Invest; 2015 Sep; 75(5):374-81. PubMed ID: 25874479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.